Adagene

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Adagene and other ETFs, options, and stocks.

About ADAG

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody.

CEO

Pei Zhi Luo

CEOPei Zhi Luo

Employees

138

Employees138

Headquarters

Suzhou, Jiangsu

HeadquartersSuzhou, Jiangsu

Founded

2011

Founded2011

Employees

138

Employees138

ADAG Key Statistics

Market cap

89.51M

Market cap89.51M

Price-Earnings ratio

-2.47

Price-Earnings ratio-2.47

Dividend yield

—

Dividend yield—

Average volume

93.28K

Average volume93.28K

High today

$2.92

High today$2.92

Low today

$1.74

Low today$1.74

Open price

$1.92

Open price$1.92

Volume

904.55K

Volume904.55K

52 Week high

$3.58

52 Week high$3.58

52 Week low

$1.33

52 Week low$1.33

Adagene

Why Robinhood?

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. Show more

ADAG Key Statistics

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody.